Piedrafita, Alexis
Siwy, Justyna
Klein, Julie
Akkari, Amal
Amaya-garrido, Ana
Mebazaa, Alexandre
Sanz, Anna Belen
Breuil, Benjamin
Montero Herrero, Laura
Marcheix, Bertrand
Depret, François
Fernandez, Lucie
Tardif, Elsa
Minville, Vincent
Alves, Melinda
Metzger, Jochen
Grunenwald, Etienne
Feuillet, Guylène
Buléon, Marie
Brunet, Manon
Mayeur, Nicolas
Casemayou, Audrey
Labaste, François
Grossac, Julia
Mischak, Harald
Ortiz, Alberto
Gazut, Stéphane
Schanstra, Joost P.
Faguer, Stanislas
,
Funding for this research was provided by:
Université Toulouse III - Paul Sabatier (Ecolde Doctorale)
ERA PerMed-JTC2018 (01KU1907, ANR-18-PERM-0003, ANR-18-PERM-0003, ANR-18-PERM-0003, ANR-18-PERM-0003, 01KU1907, 01KU1907, ANR-18-PERM-0003, ANR-18-PERM-0003, ANR-18-PERM-0003)
ERA PerMed2018-JTC (AC18/00 064)
Fondation pour la Recherche Médicale (DEQ20170336759)
Article History
Received: 30 June 2022
Accepted: 7 October 2022
First Online: 7 November 2022
Change Date: 29 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13054-022-04278-5
Declarations
:
: All the patients were orally informed of the inclusion and the non-opposition of the patients to be included in the clinical and biological collection of the University Hospital of Toulouse was obtained before inclusion (agreement number French national ethical committee DC-2008–463). The study was performed according to the Declaration of Helsinki, as revised in 2004.
: Not applicable.
: Justyna Siwy and Jochen Metzger are the employee and former employee at Mosaiques diagnostics GmbH (Hannover, Germany), respectively. Harald Mischak is the CEO of Mosaiques diagnostics GmbH. The other authors declare no competing interests.